LISA CLOUGH: Open Payments
NPI 1841459690 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,656 in 95 payments from 19 companies in 2025. Trend: 2023 $1,263 · 2024 $1,302 · 2025 $1,656
Food & beverage: $1,656
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $259 |
| GlaxoSmithKline, LLC. | 13 | $249 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $237 |
| ABBVIE INC. | 9 | $164 |
| PFIZER INC. | 12 | $159 |
| Amgen Inc. | 13 | $147 |
| Novartis Pharmaceuticals Corporation | 5 | $128 |
| Astellas Pharma US Inc | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| ViiV Healthcare Company | 2 | $38 |
Products named: CAPLYTA, Ozempic, AREXVY, LEQVIO, NURTEC ODT, QULIPTA, OTEZLA, EVENITY.
Industry payments across CO — which companies pay providers there.
